SlideShare ist ein Scribd-Unternehmen logo
1 von 2
Downloaden Sie, um offline zu lesen
Axiom®
Genome-Wide CHB 1 & CHB 2 Array Plate Set
The highest coverage of rare and common variants for association studies in Han Chinese populations
Highlights
n	 1.2 million SNPs selected from GWAS in Han
Chinese populations
n	 Comprehensive genotype-tested SNPs including
maximized rare and common allele coverage
n	 Focus on SNPs with strong disease associations
and functional relevance
n	 Cost- and analysis-efficient design using only highly
informative CHB markers to avoid redundancy
n	 Fully automatable with quick assay turnaround time
n	 Low running costs enable highly powered studies
n	 Flexible, automation-friendly data analysis software
for simplified data management
Array design/SNP selection
All of the content for Axiom®
Genome-Wide (GW) CHB 1
& CHB 2 Array Plate Set was selected from Axiom®
Genomic
Database, which contains genotype-tested markers derived
from various public sources, including the International HapMap
Project, the Single Nucleotide Polymorphism Database (dbSNP),
and the 1000 Genomes Project. Each marker was tested
extensively to ensure robust detection of the minor allele
with stringent performance criteria in the Axiom®
Assay.
Our genotype testing program gives us uniquely detailed
data on population-specific linkage disequilibrium and
haplotypes. This allows us to be highly efficient when selecting
tagging SNPs for high genomic coverage. By avoiding marker
redundancy and uninformative markers, we minimize the
numbers of SNPs needed to achieve genomic coverage.
SNPs were selected to provide maximum genome-wide
coverage including: chromosomes X and Y, mitochondrial
SNPs, cSNPs (coding SNPs), and indels (see Table 1).
Also included on the array are SNPs within functionally
relevant coding and untranslated regions (UTR) including
markers for ADME and disease-associated SNPs. SNPs
were selected from disease annotation databases such as
Gene Ontology (GO) for the cardiovascular system, Sanger
Cancer Gene Census, PharmaADME, SNPs within the Major
Histocompatibility Complex (MHC) region on chromosome
6, and SNPs originating from the National Human Genome
Research Institute (NHGRI) Catalog of Published Genome-
Wide Association Studies (see Table 1).
Comprehensive genomic coverage
The 1.2 million SNPs in Axiom Genome-Wide CHB 1 & CHB 2
Array Plate Set were chosen to deliver comprehensive coverage
of rare and common alleles in Han Chinese populations.
Axiom®
Genome-Wide (GW) CHB 1 Array Plate was designed
for high genomic coverage of common alleles, while Axiom®
Genome-wide (GW) CHB 2 Array Plate focuses on rare variants.
Axiom GW CHB 2 Array Plate was specifically designed to
supplement the content of the Axiom GW CHB 1 Array Plate.
This complementary nature is shown in Table 2.
Data Sheet
Table 1: Breakdown of SNPs by biological relevance.
Biological category
No. SNPs
Axiom
GW CHB 1
Array Plate
No. SNPs
Axiom GW
CHB 1 & CHB 2
Array Plate Set
cSNPs-nonsynonymous 4,225 10,560
cSNPs-synonymous 3,243 8,422
Splicing and UTR 7,641 20,538
Chromosome X 12,545 36,841
Chromosome Y 1,613 2,460
Indels 3,112 3,826
Mitochondrial 217 304
ADME 3,723 7,886
Genic 277,429 552,684
Inflammation and
immunity pathways
4,387 12,009
MHC 1,873 4,229
Cardiovascular N/A 14,293
NHGRI
disease-associated
2,114 2,424
Sanger Cancer
Gene Census
N/A 16,781
Total SNPs 640,674 1,282,446
Table 2: Genomic coverage of Axiom®
GW CHB 1 Array Plate and
Axiom®
GW CHB 1 & CHB 2 Array Plate Set. Pairwise genomic coverage
at r2
>0.8 for SNPs in the 1000 Genomes Project Phase 1 integrated
release Dec 2011; Han Chinese in Beijing (CHB), Han Chinese South (CHS),
and Japanese in Tokyo (JPT) alleles.
Axiom GW
CHB 1
Array Plate
Axiom GW CHB
1 & CHB 2 Array
Plate Set
Other
commercially
available
Chinese array
Population
MAF
>2%
MAF
>5%
MAF
>2%
MAF
>5%
MAF
>2%
MAF
>5%
CHB 66% 77% 80% 86% 72% 79%
CHS 64% 75% 79% 86% 72% 79%
JPT 64% 72% 78% 84% 72% 78%
Superior assay performance
As shown in Table 3, Axiom®
Genome-Wide CHB 1 & CHB 2
Array Plate Set has superior technical performance offering high
confidence for genome-wide association studies.
Table 3: Performance achieved by Axiom GW CHB 1 & CHB 2
Array Plate Set. Calculated based on 190 Chinese and Japanese
HapMap samples.
Performance metric Specification
Average SNP call rate >99%
Average HapMap concordance >99.5%
Average reproducibility >99.7%
Ordering information
Part number Description Details
901843 Axiom®
Genome-Wide CHB 1
& CHB 2 Array Set Bundle
Sufficient for processing 96 gDNA samples, includes:
	 n
	 One Axiom Genome-Wide CHB 1 96-Array Plate
	 n
	 One Axiom Genome-Wide CHB 2 96-Array Plate
	 n
	 Two Axiom®
2.0 Reagent Kits
	 n
	 Two Axiom®
GeneTitan®
Consumables Kits
901764 Axiom®
Genome-Wide CHB 1 Array Plate Contains one Axiom Genome-Wide CHB 1 96-Array Plate
901842 Axiom®
Genome-Wide CHB 2 Array Plate Contains one Axiom Genome-Wide CHB 2 96-Array Plate
901758 Axiom®
2.0 Reagent Kit Contains all reagents (except isopropanol) required to process 96 gDNA samples
901606 Axiom®
GeneTitan®
Consumables Kit Contains all GeneTitan®
Instrument consumables required to process one Axiom®
Array Plate
0000740 Axiom®
Genotyping Services
Sample processing and data generation services for gDNA samples (minimum 1,000
samples) using the Axiom Genotyping Solution
www.affymetrix.com Please visit our website for international distributor contact information.
“For Research Use Only. Not for use in diagnostic procedures.”
P/N DNA01393 Rev. 1
©Affymetrix, Inc. All rights reserved. Affymetrix®
, Axiom®
, Command Console®
, CytoScan™
, DMET™
, GeneAtlas®
, GeneChip®
, GeneChip-compatible™
, GeneTitan®
, Genotyping Console™
, myDesign™
, NetAffx®
,
OncoScan™
, Powered by Affymetrix™
, PrimeView™
, Procarta®
, and QuantiGene®
are trademarks or registered trademarks of Affymetrix, Inc. All other trademarks are the property of their respective owners.
Products may be covered by one or more of the following patents: U.S. Patent Nos. 5,445,934; 5,744,305; 5,945,334; 6,140,044; 6,399,365; 6,420,169; 6,551,817; 6,733,977; 7,629,164; 7,790,389
and D430,024 and other U.S. or foreign patents. Products are manufactured and sold under license from OGT under 5,700,637 and 6,054,270.
Affymetrix, Inc. Tel: +1-888-362-2447  Affymetrix UK Ltd. Tel: +44-(0)-1628-552550  Affymetrix Japan K.K. Tel: +81-(0)3-6430-4020
Panomics Products Tel: +1-877-PANOMICS www.panomics.com  USB Products Tel: +1-800-321-9322 www.usb.affymetrix.com
Quick assay turnaround time
Axiom Genome-Wide CHB 1 & CHB 2 Array Plate Set is part
of Axiom®
Genotyping Solution, which uses Axiom®
2.0 Assay.
The assay is fully automatable on Affymetrix GeneTitan®
Multi-
Channel Instrument for array processing.
n	 Minimal operator intervention – load consumables, press start,
then view analysis
n	 High throughput – instrument operates overnight and can
manage over 760 samples/week
n	 Time efficient – less than 2.5 hours of hands-on time per
96 samples
	
Flexible data analysis software
Integrate Microsoft Windows GUI-based Genotyping Console™
Software (GTC) or automation-friendly command line-based
Affymetrix Power Tools for completing the primary genotyping
analysis. The flexible software workflow with simplified data
management allows you to easily share your results and seamlessly
integrate with third-party software packages.
Sample types supported
n	 gDNA from fresh blood
n	 gDNA from saliva (collected using Oragene®
DNA collection kits
from DNA Genotek)
n	 Whole-genome amplified (WGA) DNA (amplified from gDNA
using QIAGEN Repli-g®
kits)

Weitere ähnliche Inhalte

Was ist angesagt?

Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...Matthias Samwald
 
Specific inhibition of CK2α from an anchor outside the active site
Specific inhibition of CK2α from an anchor outside the active siteSpecific inhibition of CK2α from an anchor outside the active site
Specific inhibition of CK2α from an anchor outside the active sitePaul Brear
 
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...Thermo Fisher Scientific
 
Dr. Yao-Wei Huang - Here we go again? Emergence of a novel swine enteric alph...
Dr. Yao-Wei Huang - Here we go again? Emergence of a novel swine enteric alph...Dr. Yao-Wei Huang - Here we go again? Emergence of a novel swine enteric alph...
Dr. Yao-Wei Huang - Here we go again? Emergence of a novel swine enteric alph...John Blue
 
Identify Compounds that Rescue Disease Relevant Mutant Membrane Proteins
Identify Compounds that Rescue Disease Relevant Mutant Membrane ProteinsIdentify Compounds that Rescue Disease Relevant Mutant Membrane Proteins
Identify Compounds that Rescue Disease Relevant Mutant Membrane ProteinsDiscoverX Corporation
 
Aug2013 tumor normal whole genome sequencing
Aug2013 tumor normal whole genome sequencingAug2013 tumor normal whole genome sequencing
Aug2013 tumor normal whole genome sequencingGenomeInABottle
 
Effects of CTGF Overexpression on Fibrosis-Related Phenotypes
Effects of CTGF Overexpression on Fibrosis-Related PhenotypesEffects of CTGF Overexpression on Fibrosis-Related Phenotypes
Effects of CTGF Overexpression on Fibrosis-Related PhenotypesAshley Kennedy
 
Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse...
Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse...Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse...
Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse...InsideScientific
 
Identification and characterization of micro rn as expressed in hiv
Identification and characterization of micro rn as expressed in hivIdentification and characterization of micro rn as expressed in hiv
Identification and characterization of micro rn as expressed in hivTaahira Goolam Hoosen (Moola)
 
Introducing Genomic Testing Cooperative (GTC)
Introducing Genomic Testing Cooperative (GTC)Introducing Genomic Testing Cooperative (GTC)
Introducing Genomic Testing Cooperative (GTC)George Arndt
 

Was ist angesagt? (11)

Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
Medinfo2013 - An RDF/OWL Knowledge Base for Query Answering and Decision Supp...
 
Specific inhibition of CK2α from an anchor outside the active site
Specific inhibition of CK2α from an anchor outside the active siteSpecific inhibition of CK2α from an anchor outside the active site
Specific inhibition of CK2α from an anchor outside the active site
 
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...
 
Dr. Yao-Wei Huang - Here we go again? Emergence of a novel swine enteric alph...
Dr. Yao-Wei Huang - Here we go again? Emergence of a novel swine enteric alph...Dr. Yao-Wei Huang - Here we go again? Emergence of a novel swine enteric alph...
Dr. Yao-Wei Huang - Here we go again? Emergence of a novel swine enteric alph...
 
Identify Compounds that Rescue Disease Relevant Mutant Membrane Proteins
Identify Compounds that Rescue Disease Relevant Mutant Membrane ProteinsIdentify Compounds that Rescue Disease Relevant Mutant Membrane Proteins
Identify Compounds that Rescue Disease Relevant Mutant Membrane Proteins
 
Aug2013 tumor normal whole genome sequencing
Aug2013 tumor normal whole genome sequencingAug2013 tumor normal whole genome sequencing
Aug2013 tumor normal whole genome sequencing
 
Effects of CTGF Overexpression on Fibrosis-Related Phenotypes
Effects of CTGF Overexpression on Fibrosis-Related PhenotypesEffects of CTGF Overexpression on Fibrosis-Related Phenotypes
Effects of CTGF Overexpression on Fibrosis-Related Phenotypes
 
Nous reptes de la Medicina de Precisió
Nous reptes de la Medicina de PrecisióNous reptes de la Medicina de Precisió
Nous reptes de la Medicina de Precisió
 
Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse...
Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse...Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse...
Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse...
 
Identification and characterization of micro rn as expressed in hiv
Identification and characterization of micro rn as expressed in hivIdentification and characterization of micro rn as expressed in hiv
Identification and characterization of micro rn as expressed in hiv
 
Introducing Genomic Testing Cooperative (GTC)
Introducing Genomic Testing Cooperative (GTC)Introducing Genomic Testing Cooperative (GTC)
Introducing Genomic Testing Cooperative (GTC)
 

Ähnlich wie Axiom® Genome-Wide CHB 1 & CHB 2 Array Plate Set

Axiom® Biobank Genotyping Arrays
Axiom® Biobank Genotyping ArraysAxiom® Biobank Genotyping Arrays
Axiom® Biobank Genotyping ArraysAffymetrix
 
Axiom® Genome-Wide AFR 1 Array World Array 3
Axiom®  Genome-Wide AFR 1 Array World Array 3Axiom®  Genome-Wide AFR 1 Array World Array 3
Axiom® Genome-Wide AFR 1 Array World Array 3Affymetrix
 
Axiom™ Genome-Wide ASI 1 Array Plate
Axiom™ Genome-Wide ASI 1 Array PlateAxiom™ Genome-Wide ASI 1 Array Plate
Axiom™ Genome-Wide ASI 1 Array PlateAffymetrix
 
Axiom™ Genome-Wide CEU 1 Array Plate
Axiom™ Genome-Wide CEU 1 Array PlateAxiom™ Genome-Wide CEU 1 Array Plate
Axiom™ Genome-Wide CEU 1 Array PlateAffymetrix
 
Axiom® Genome-Wide LAT 1 Array World Array 4
Axiom®  Genome-Wide LAT 1 Array World Array 4Axiom®  Genome-Wide LAT 1 Array World Array 4
Axiom® Genome-Wide LAT 1 Array World Array 4Affymetrix
 
A novel method for building custom ampli seq panels using optimized pcr primers
A novel method for building custom ampli seq panels using optimized pcr primers A novel method for building custom ampli seq panels using optimized pcr primers
A novel method for building custom ampli seq panels using optimized pcr primers Thermo Fisher Scientific
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
GIAB for AMP GeT-RM Forum
GIAB for AMP GeT-RM ForumGIAB for AMP GeT-RM Forum
GIAB for AMP GeT-RM ForumGenomeInABottle
 
Genome in a Bottle- reference materials to benchmark challenging variants and...
Genome in a Bottle- reference materials to benchmark challenging variants and...Genome in a Bottle- reference materials to benchmark challenging variants and...
Genome in a Bottle- reference materials to benchmark challenging variants and...GenomeInABottle
 
Development of a high-throughput high-density SNP genotyping array for bovine
Development of a high-throughput high-density SNP genotyping array for bovineDevelopment of a high-throughput high-density SNP genotyping array for bovine
Development of a high-throughput high-density SNP genotyping array for bovineAffymetrix
 
A next generation sequencing based sample-to-result pharmacogenomics research...
A next generation sequencing based sample-to-result pharmacogenomics research...A next generation sequencing based sample-to-result pharmacogenomics research...
A next generation sequencing based sample-to-result pharmacogenomics research...Thermo Fisher Scientific
 
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...Integrated DNA Technologies
 
Automating the ACMG Guidelines with VSClinical
Automating the ACMG Guidelines with VSClinicalAutomating the ACMG Guidelines with VSClinical
Automating the ACMG Guidelines with VSClinicalGolden Helix
 
Heptotox biomarker discovery Ontomine
Heptotox biomarker discovery OntomineHeptotox biomarker discovery Ontomine
Heptotox biomarker discovery OntomineRajeev Gangal
 
Global Gene Expression Profiles from Bladder Tumor FFPE Samples
Global Gene Expression Profiles from Bladder Tumor FFPE SamplesGlobal Gene Expression Profiles from Bladder Tumor FFPE Samples
Global Gene Expression Profiles from Bladder Tumor FFPE SamplesThermo Fisher Scientific
 
Apac distributor training series 3 swift product for cancer study
Apac distributor training series 3  swift product for cancer studyApac distributor training series 3  swift product for cancer study
Apac distributor training series 3 swift product for cancer studySwift Biosciences
 
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...GenomeInABottle
 

Ähnlich wie Axiom® Genome-Wide CHB 1 & CHB 2 Array Plate Set (20)

Axiom® Biobank Genotyping Arrays
Axiom® Biobank Genotyping ArraysAxiom® Biobank Genotyping Arrays
Axiom® Biobank Genotyping Arrays
 
Axiom® Genome-Wide AFR 1 Array World Array 3
Axiom®  Genome-Wide AFR 1 Array World Array 3Axiom®  Genome-Wide AFR 1 Array World Array 3
Axiom® Genome-Wide AFR 1 Array World Array 3
 
Axiom™ Genome-Wide ASI 1 Array Plate
Axiom™ Genome-Wide ASI 1 Array PlateAxiom™ Genome-Wide ASI 1 Array Plate
Axiom™ Genome-Wide ASI 1 Array Plate
 
Axiom™ Genome-Wide CEU 1 Array Plate
Axiom™ Genome-Wide CEU 1 Array PlateAxiom™ Genome-Wide CEU 1 Array Plate
Axiom™ Genome-Wide CEU 1 Array Plate
 
Axiom® Genome-Wide LAT 1 Array World Array 4
Axiom®  Genome-Wide LAT 1 Array World Array 4Axiom®  Genome-Wide LAT 1 Array World Array 4
Axiom® Genome-Wide LAT 1 Array World Array 4
 
A novel method for building custom ampli seq panels using optimized pcr primers
A novel method for building custom ampli seq panels using optimized pcr primers A novel method for building custom ampli seq panels using optimized pcr primers
A novel method for building custom ampli seq panels using optimized pcr primers
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
2023 GIAB AMP Update
2023 GIAB AMP Update2023 GIAB AMP Update
2023 GIAB AMP Update
 
Dna microarrays
Dna microarraysDna microarrays
Dna microarrays
 
Axt microarrays
Axt microarraysAxt microarrays
Axt microarrays
 
GIAB for AMP GeT-RM Forum
GIAB for AMP GeT-RM ForumGIAB for AMP GeT-RM Forum
GIAB for AMP GeT-RM Forum
 
Genome in a Bottle- reference materials to benchmark challenging variants and...
Genome in a Bottle- reference materials to benchmark challenging variants and...Genome in a Bottle- reference materials to benchmark challenging variants and...
Genome in a Bottle- reference materials to benchmark challenging variants and...
 
Development of a high-throughput high-density SNP genotyping array for bovine
Development of a high-throughput high-density SNP genotyping array for bovineDevelopment of a high-throughput high-density SNP genotyping array for bovine
Development of a high-throughput high-density SNP genotyping array for bovine
 
A next generation sequencing based sample-to-result pharmacogenomics research...
A next generation sequencing based sample-to-result pharmacogenomics research...A next generation sequencing based sample-to-result pharmacogenomics research...
A next generation sequencing based sample-to-result pharmacogenomics research...
 
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
Characterizing Alzheimer’s Disease candidate genes and transcripts with targe...
 
Automating the ACMG Guidelines with VSClinical
Automating the ACMG Guidelines with VSClinicalAutomating the ACMG Guidelines with VSClinical
Automating the ACMG Guidelines with VSClinical
 
Heptotox biomarker discovery Ontomine
Heptotox biomarker discovery OntomineHeptotox biomarker discovery Ontomine
Heptotox biomarker discovery Ontomine
 
Global Gene Expression Profiles from Bladder Tumor FFPE Samples
Global Gene Expression Profiles from Bladder Tumor FFPE SamplesGlobal Gene Expression Profiles from Bladder Tumor FFPE Samples
Global Gene Expression Profiles from Bladder Tumor FFPE Samples
 
Apac distributor training series 3 swift product for cancer study
Apac distributor training series 3  swift product for cancer studyApac distributor training series 3  swift product for cancer study
Apac distributor training series 3 swift product for cancer study
 
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
 

Mehr von Affymetrix

SNP genotyping using the Affymetrix® Axiom® Genome-Wide Pan-African (PanAFR) ...
SNP genotyping using the Affymetrix® Axiom® Genome-Wide Pan-African (PanAFR) ...SNP genotyping using the Affymetrix® Axiom® Genome-Wide Pan-African (PanAFR) ...
SNP genotyping using the Affymetrix® Axiom® Genome-Wide Pan-African (PanAFR) ...Affymetrix
 
A SNP array for human population genetics studies
A SNP array for human population genetics studiesA SNP array for human population genetics studies
A SNP array for human population genetics studiesAffymetrix
 
FFPE Applications Solutions brochure
FFPE Applications Solutions brochureFFPE Applications Solutions brochure
FFPE Applications Solutions brochureAffymetrix
 
Solutions for Personalized Medicine brochure
Solutions for Personalized Medicine brochureSolutions for Personalized Medicine brochure
Solutions for Personalized Medicine brochureAffymetrix
 
Download our publication archive list
Download our publication archive listDownload our publication archive list
Download our publication archive listAffymetrix
 
Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq Affymetrix
 
Designing GWAS arrays for efficient imputation-based coverage
Designing GWAS arrays for efficient imputation-based coverageDesigning GWAS arrays for efficient imputation-based coverage
Designing GWAS arrays for efficient imputation-based coverageAffymetrix
 
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...Affymetrix
 
From trials evaluating drugs to trials evaluating treatment algorithms – Focu...
From trials evaluating drugs to trials evaluating treatment algorithms – Focu...From trials evaluating drugs to trials evaluating treatment algorithms – Focu...
From trials evaluating drugs to trials evaluating treatment algorithms – Focu...Affymetrix
 
Affymetrix OncoScan®* data analysis with Nexus Copy Number™
Affymetrix OncoScan®* data analysis with Nexus Copy Number™Affymetrix OncoScan®* data analysis with Nexus Copy Number™
Affymetrix OncoScan®* data analysis with Nexus Copy Number™Affymetrix
 
Phenotypic identification of subclones in multiple myeloma with different gen...
Phenotypic identification of subclones in multiple myeloma with different gen...Phenotypic identification of subclones in multiple myeloma with different gen...
Phenotypic identification of subclones in multiple myeloma with different gen...Affymetrix
 
Mitigating genotyping application note
Mitigating genotyping application noteMitigating genotyping application note
Mitigating genotyping application noteAffymetrix
 
Statistical methods for off-target variant genotyping on Affymetrix' Axiom Ar...
Statistical methods for off-target variant genotyping on Affymetrix' Axiom Ar...Statistical methods for off-target variant genotyping on Affymetrix' Axiom Ar...
Statistical methods for off-target variant genotyping on Affymetrix' Axiom Ar...Affymetrix
 
Allopolyploid Genotyping Algorithm on Affymetrix' Axiom Arrays
Allopolyploid Genotyping Algorithm on Affymetrix' Axiom ArraysAllopolyploid Genotyping Algorithm on Affymetrix' Axiom Arrays
Allopolyploid Genotyping Algorithm on Affymetrix' Axiom ArraysAffymetrix
 
SNP genotyping of markers with nearby secondary polymorphisms using Affymetri...
SNP genotyping of markers with nearby secondary polymorphisms using Affymetri...SNP genotyping of markers with nearby secondary polymorphisms using Affymetri...
SNP genotyping of markers with nearby secondary polymorphisms using Affymetri...Affymetrix
 
Best practices for genotyping analysis of plant and animal genomes with Affym...
Best practices for genotyping analysis of plant and animal genomes with Affym...Best practices for genotyping analysis of plant and animal genomes with Affym...
Best practices for genotyping analysis of plant and animal genomes with Affym...Affymetrix
 
SNP genotyping using Affymetrix' Axiom Genotyping Solution
SNP genotyping using Affymetrix' Axiom Genotyping SolutionSNP genotyping using Affymetrix' Axiom Genotyping Solution
SNP genotyping using Affymetrix' Axiom Genotyping SolutionAffymetrix
 

Mehr von Affymetrix (17)

SNP genotyping using the Affymetrix® Axiom® Genome-Wide Pan-African (PanAFR) ...
SNP genotyping using the Affymetrix® Axiom® Genome-Wide Pan-African (PanAFR) ...SNP genotyping using the Affymetrix® Axiom® Genome-Wide Pan-African (PanAFR) ...
SNP genotyping using the Affymetrix® Axiom® Genome-Wide Pan-African (PanAFR) ...
 
A SNP array for human population genetics studies
A SNP array for human population genetics studiesA SNP array for human population genetics studies
A SNP array for human population genetics studies
 
FFPE Applications Solutions brochure
FFPE Applications Solutions brochureFFPE Applications Solutions brochure
FFPE Applications Solutions brochure
 
Solutions for Personalized Medicine brochure
Solutions for Personalized Medicine brochureSolutions for Personalized Medicine brochure
Solutions for Personalized Medicine brochure
 
Download our publication archive list
Download our publication archive listDownload our publication archive list
Download our publication archive list
 
Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq
 
Designing GWAS arrays for efficient imputation-based coverage
Designing GWAS arrays for efficient imputation-based coverageDesigning GWAS arrays for efficient imputation-based coverage
Designing GWAS arrays for efficient imputation-based coverage
 
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
 
From trials evaluating drugs to trials evaluating treatment algorithms – Focu...
From trials evaluating drugs to trials evaluating treatment algorithms – Focu...From trials evaluating drugs to trials evaluating treatment algorithms – Focu...
From trials evaluating drugs to trials evaluating treatment algorithms – Focu...
 
Affymetrix OncoScan®* data analysis with Nexus Copy Number™
Affymetrix OncoScan®* data analysis with Nexus Copy Number™Affymetrix OncoScan®* data analysis with Nexus Copy Number™
Affymetrix OncoScan®* data analysis with Nexus Copy Number™
 
Phenotypic identification of subclones in multiple myeloma with different gen...
Phenotypic identification of subclones in multiple myeloma with different gen...Phenotypic identification of subclones in multiple myeloma with different gen...
Phenotypic identification of subclones in multiple myeloma with different gen...
 
Mitigating genotyping application note
Mitigating genotyping application noteMitigating genotyping application note
Mitigating genotyping application note
 
Statistical methods for off-target variant genotyping on Affymetrix' Axiom Ar...
Statistical methods for off-target variant genotyping on Affymetrix' Axiom Ar...Statistical methods for off-target variant genotyping on Affymetrix' Axiom Ar...
Statistical methods for off-target variant genotyping on Affymetrix' Axiom Ar...
 
Allopolyploid Genotyping Algorithm on Affymetrix' Axiom Arrays
Allopolyploid Genotyping Algorithm on Affymetrix' Axiom ArraysAllopolyploid Genotyping Algorithm on Affymetrix' Axiom Arrays
Allopolyploid Genotyping Algorithm on Affymetrix' Axiom Arrays
 
SNP genotyping of markers with nearby secondary polymorphisms using Affymetri...
SNP genotyping of markers with nearby secondary polymorphisms using Affymetri...SNP genotyping of markers with nearby secondary polymorphisms using Affymetri...
SNP genotyping of markers with nearby secondary polymorphisms using Affymetri...
 
Best practices for genotyping analysis of plant and animal genomes with Affym...
Best practices for genotyping analysis of plant and animal genomes with Affym...Best practices for genotyping analysis of plant and animal genomes with Affym...
Best practices for genotyping analysis of plant and animal genomes with Affym...
 
SNP genotyping using Affymetrix' Axiom Genotyping Solution
SNP genotyping using Affymetrix' Axiom Genotyping SolutionSNP genotyping using Affymetrix' Axiom Genotyping Solution
SNP genotyping using Affymetrix' Axiom Genotyping Solution
 

Kürzlich hochgeladen

Environmental Acoustics- Speech interference level, acoustics calibrator.pptx
Environmental Acoustics- Speech interference level, acoustics calibrator.pptxEnvironmental Acoustics- Speech interference level, acoustics calibrator.pptx
Environmental Acoustics- Speech interference level, acoustics calibrator.pptxpriyankatabhane
 
Q4-Mod-1c-Quiz-Projectile-333344444.pptx
Q4-Mod-1c-Quiz-Projectile-333344444.pptxQ4-Mod-1c-Quiz-Projectile-333344444.pptx
Q4-Mod-1c-Quiz-Projectile-333344444.pptxtuking87
 
Quarter 4_Grade 8_Digestive System Structure and Functions
Quarter 4_Grade 8_Digestive System Structure and FunctionsQuarter 4_Grade 8_Digestive System Structure and Functions
Quarter 4_Grade 8_Digestive System Structure and FunctionsCharlene Llagas
 
Introduction of Human Body & Structure of cell.pptx
Introduction of Human Body & Structure of cell.pptxIntroduction of Human Body & Structure of cell.pptx
Introduction of Human Body & Structure of cell.pptxMedical College
 
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书zdzoqco
 
Environmental acoustics- noise criteria.pptx
Environmental acoustics- noise criteria.pptxEnvironmental acoustics- noise criteria.pptx
Environmental acoustics- noise criteria.pptxpriyankatabhane
 
whole genome sequencing new and its types including shortgun and clone by clone
whole genome sequencing new  and its types including shortgun and clone by clonewhole genome sequencing new  and its types including shortgun and clone by clone
whole genome sequencing new and its types including shortgun and clone by clonechaudhary charan shingh university
 
6.2 Pests of Sesame_Identification_Binomics_Dr.UPR
6.2 Pests of Sesame_Identification_Binomics_Dr.UPR6.2 Pests of Sesame_Identification_Binomics_Dr.UPR
6.2 Pests of Sesame_Identification_Binomics_Dr.UPRPirithiRaju
 
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPRPirithiRaju
 
KDIGO-2023-CKD-Guideline-Public-Review-Draft_5-July-2023.pdf
KDIGO-2023-CKD-Guideline-Public-Review-Draft_5-July-2023.pdfKDIGO-2023-CKD-Guideline-Public-Review-Draft_5-July-2023.pdf
KDIGO-2023-CKD-Guideline-Public-Review-Draft_5-July-2023.pdfGABYFIORELAMALPARTID1
 
Pests of Sunflower_Binomics_Identification_Dr.UPR
Pests of Sunflower_Binomics_Identification_Dr.UPRPests of Sunflower_Binomics_Identification_Dr.UPR
Pests of Sunflower_Binomics_Identification_Dr.UPRPirithiRaju
 
Explainable AI for distinguishing future climate change scenarios
Explainable AI for distinguishing future climate change scenariosExplainable AI for distinguishing future climate change scenarios
Explainable AI for distinguishing future climate change scenariosZachary Labe
 
Observational constraints on mergers creating magnetism in massive stars
Observational constraints on mergers creating magnetism in massive starsObservational constraints on mergers creating magnetism in massive stars
Observational constraints on mergers creating magnetism in massive starsSérgio Sacani
 
well logging & petrophysical analysis.pptx
well logging & petrophysical analysis.pptxwell logging & petrophysical analysis.pptx
well logging & petrophysical analysis.pptxzaydmeerab121
 
CHROMATOGRAPHY PALLAVI RAWAT.pptx
CHROMATOGRAPHY  PALLAVI RAWAT.pptxCHROMATOGRAPHY  PALLAVI RAWAT.pptx
CHROMATOGRAPHY PALLAVI RAWAT.pptxpallavirawat456
 
LESSON PLAN IN SCIENCE GRADE 4 WEEK 1 DAY 2
LESSON PLAN IN SCIENCE GRADE 4 WEEK 1 DAY 2LESSON PLAN IN SCIENCE GRADE 4 WEEK 1 DAY 2
LESSON PLAN IN SCIENCE GRADE 4 WEEK 1 DAY 2AuEnriquezLontok
 
Oxo-Acids of Halogens and their Salts.pptx
Oxo-Acids of Halogens and their Salts.pptxOxo-Acids of Halogens and their Salts.pptx
Oxo-Acids of Halogens and their Salts.pptxfarhanvvdk
 

Kürzlich hochgeladen (20)

Environmental Acoustics- Speech interference level, acoustics calibrator.pptx
Environmental Acoustics- Speech interference level, acoustics calibrator.pptxEnvironmental Acoustics- Speech interference level, acoustics calibrator.pptx
Environmental Acoustics- Speech interference level, acoustics calibrator.pptx
 
Q4-Mod-1c-Quiz-Projectile-333344444.pptx
Q4-Mod-1c-Quiz-Projectile-333344444.pptxQ4-Mod-1c-Quiz-Projectile-333344444.pptx
Q4-Mod-1c-Quiz-Projectile-333344444.pptx
 
Interferons.pptx.
Interferons.pptx.Interferons.pptx.
Interferons.pptx.
 
Quarter 4_Grade 8_Digestive System Structure and Functions
Quarter 4_Grade 8_Digestive System Structure and FunctionsQuarter 4_Grade 8_Digestive System Structure and Functions
Quarter 4_Grade 8_Digestive System Structure and Functions
 
Introduction of Human Body & Structure of cell.pptx
Introduction of Human Body & Structure of cell.pptxIntroduction of Human Body & Structure of cell.pptx
Introduction of Human Body & Structure of cell.pptx
 
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书
 
Environmental acoustics- noise criteria.pptx
Environmental acoustics- noise criteria.pptxEnvironmental acoustics- noise criteria.pptx
Environmental acoustics- noise criteria.pptx
 
whole genome sequencing new and its types including shortgun and clone by clone
whole genome sequencing new  and its types including shortgun and clone by clonewhole genome sequencing new  and its types including shortgun and clone by clone
whole genome sequencing new and its types including shortgun and clone by clone
 
6.2 Pests of Sesame_Identification_Binomics_Dr.UPR
6.2 Pests of Sesame_Identification_Binomics_Dr.UPR6.2 Pests of Sesame_Identification_Binomics_Dr.UPR
6.2 Pests of Sesame_Identification_Binomics_Dr.UPR
 
AZOTOBACTER AS BIOFERILIZER.PPTX
AZOTOBACTER AS BIOFERILIZER.PPTXAZOTOBACTER AS BIOFERILIZER.PPTX
AZOTOBACTER AS BIOFERILIZER.PPTX
 
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR
 
KDIGO-2023-CKD-Guideline-Public-Review-Draft_5-July-2023.pdf
KDIGO-2023-CKD-Guideline-Public-Review-Draft_5-July-2023.pdfKDIGO-2023-CKD-Guideline-Public-Review-Draft_5-July-2023.pdf
KDIGO-2023-CKD-Guideline-Public-Review-Draft_5-July-2023.pdf
 
Pests of Sunflower_Binomics_Identification_Dr.UPR
Pests of Sunflower_Binomics_Identification_Dr.UPRPests of Sunflower_Binomics_Identification_Dr.UPR
Pests of Sunflower_Binomics_Identification_Dr.UPR
 
Explainable AI for distinguishing future climate change scenarios
Explainable AI for distinguishing future climate change scenariosExplainable AI for distinguishing future climate change scenarios
Explainable AI for distinguishing future climate change scenarios
 
Observational constraints on mergers creating magnetism in massive stars
Observational constraints on mergers creating magnetism in massive starsObservational constraints on mergers creating magnetism in massive stars
Observational constraints on mergers creating magnetism in massive stars
 
well logging & petrophysical analysis.pptx
well logging & petrophysical analysis.pptxwell logging & petrophysical analysis.pptx
well logging & petrophysical analysis.pptx
 
CHROMATOGRAPHY PALLAVI RAWAT.pptx
CHROMATOGRAPHY  PALLAVI RAWAT.pptxCHROMATOGRAPHY  PALLAVI RAWAT.pptx
CHROMATOGRAPHY PALLAVI RAWAT.pptx
 
LESSON PLAN IN SCIENCE GRADE 4 WEEK 1 DAY 2
LESSON PLAN IN SCIENCE GRADE 4 WEEK 1 DAY 2LESSON PLAN IN SCIENCE GRADE 4 WEEK 1 DAY 2
LESSON PLAN IN SCIENCE GRADE 4 WEEK 1 DAY 2
 
PLASMODIUM. PPTX
PLASMODIUM. PPTXPLASMODIUM. PPTX
PLASMODIUM. PPTX
 
Oxo-Acids of Halogens and their Salts.pptx
Oxo-Acids of Halogens and their Salts.pptxOxo-Acids of Halogens and their Salts.pptx
Oxo-Acids of Halogens and their Salts.pptx
 

Axiom® Genome-Wide CHB 1 & CHB 2 Array Plate Set

  • 1. Axiom® Genome-Wide CHB 1 & CHB 2 Array Plate Set The highest coverage of rare and common variants for association studies in Han Chinese populations Highlights n 1.2 million SNPs selected from GWAS in Han Chinese populations n Comprehensive genotype-tested SNPs including maximized rare and common allele coverage n Focus on SNPs with strong disease associations and functional relevance n Cost- and analysis-efficient design using only highly informative CHB markers to avoid redundancy n Fully automatable with quick assay turnaround time n Low running costs enable highly powered studies n Flexible, automation-friendly data analysis software for simplified data management Array design/SNP selection All of the content for Axiom® Genome-Wide (GW) CHB 1 & CHB 2 Array Plate Set was selected from Axiom® Genomic Database, which contains genotype-tested markers derived from various public sources, including the International HapMap Project, the Single Nucleotide Polymorphism Database (dbSNP), and the 1000 Genomes Project. Each marker was tested extensively to ensure robust detection of the minor allele with stringent performance criteria in the Axiom® Assay. Our genotype testing program gives us uniquely detailed data on population-specific linkage disequilibrium and haplotypes. This allows us to be highly efficient when selecting tagging SNPs for high genomic coverage. By avoiding marker redundancy and uninformative markers, we minimize the numbers of SNPs needed to achieve genomic coverage. SNPs were selected to provide maximum genome-wide coverage including: chromosomes X and Y, mitochondrial SNPs, cSNPs (coding SNPs), and indels (see Table 1). Also included on the array are SNPs within functionally relevant coding and untranslated regions (UTR) including markers for ADME and disease-associated SNPs. SNPs were selected from disease annotation databases such as Gene Ontology (GO) for the cardiovascular system, Sanger Cancer Gene Census, PharmaADME, SNPs within the Major Histocompatibility Complex (MHC) region on chromosome 6, and SNPs originating from the National Human Genome Research Institute (NHGRI) Catalog of Published Genome- Wide Association Studies (see Table 1). Comprehensive genomic coverage The 1.2 million SNPs in Axiom Genome-Wide CHB 1 & CHB 2 Array Plate Set were chosen to deliver comprehensive coverage of rare and common alleles in Han Chinese populations. Axiom® Genome-Wide (GW) CHB 1 Array Plate was designed for high genomic coverage of common alleles, while Axiom® Genome-wide (GW) CHB 2 Array Plate focuses on rare variants. Axiom GW CHB 2 Array Plate was specifically designed to supplement the content of the Axiom GW CHB 1 Array Plate. This complementary nature is shown in Table 2. Data Sheet Table 1: Breakdown of SNPs by biological relevance. Biological category No. SNPs Axiom GW CHB 1 Array Plate No. SNPs Axiom GW CHB 1 & CHB 2 Array Plate Set cSNPs-nonsynonymous 4,225 10,560 cSNPs-synonymous 3,243 8,422 Splicing and UTR 7,641 20,538 Chromosome X 12,545 36,841 Chromosome Y 1,613 2,460 Indels 3,112 3,826 Mitochondrial 217 304 ADME 3,723 7,886 Genic 277,429 552,684 Inflammation and immunity pathways 4,387 12,009 MHC 1,873 4,229 Cardiovascular N/A 14,293 NHGRI disease-associated 2,114 2,424 Sanger Cancer Gene Census N/A 16,781 Total SNPs 640,674 1,282,446
  • 2. Table 2: Genomic coverage of Axiom® GW CHB 1 Array Plate and Axiom® GW CHB 1 & CHB 2 Array Plate Set. Pairwise genomic coverage at r2 >0.8 for SNPs in the 1000 Genomes Project Phase 1 integrated release Dec 2011; Han Chinese in Beijing (CHB), Han Chinese South (CHS), and Japanese in Tokyo (JPT) alleles. Axiom GW CHB 1 Array Plate Axiom GW CHB 1 & CHB 2 Array Plate Set Other commercially available Chinese array Population MAF >2% MAF >5% MAF >2% MAF >5% MAF >2% MAF >5% CHB 66% 77% 80% 86% 72% 79% CHS 64% 75% 79% 86% 72% 79% JPT 64% 72% 78% 84% 72% 78% Superior assay performance As shown in Table 3, Axiom® Genome-Wide CHB 1 & CHB 2 Array Plate Set has superior technical performance offering high confidence for genome-wide association studies. Table 3: Performance achieved by Axiom GW CHB 1 & CHB 2 Array Plate Set. Calculated based on 190 Chinese and Japanese HapMap samples. Performance metric Specification Average SNP call rate >99% Average HapMap concordance >99.5% Average reproducibility >99.7% Ordering information Part number Description Details 901843 Axiom® Genome-Wide CHB 1 & CHB 2 Array Set Bundle Sufficient for processing 96 gDNA samples, includes: n One Axiom Genome-Wide CHB 1 96-Array Plate n One Axiom Genome-Wide CHB 2 96-Array Plate n Two Axiom® 2.0 Reagent Kits n Two Axiom® GeneTitan® Consumables Kits 901764 Axiom® Genome-Wide CHB 1 Array Plate Contains one Axiom Genome-Wide CHB 1 96-Array Plate 901842 Axiom® Genome-Wide CHB 2 Array Plate Contains one Axiom Genome-Wide CHB 2 96-Array Plate 901758 Axiom® 2.0 Reagent Kit Contains all reagents (except isopropanol) required to process 96 gDNA samples 901606 Axiom® GeneTitan® Consumables Kit Contains all GeneTitan® Instrument consumables required to process one Axiom® Array Plate 0000740 Axiom® Genotyping Services Sample processing and data generation services for gDNA samples (minimum 1,000 samples) using the Axiom Genotyping Solution www.affymetrix.com Please visit our website for international distributor contact information. “For Research Use Only. Not for use in diagnostic procedures.” P/N DNA01393 Rev. 1 ©Affymetrix, Inc. All rights reserved. Affymetrix® , Axiom® , Command Console® , CytoScan™ , DMET™ , GeneAtlas® , GeneChip® , GeneChip-compatible™ , GeneTitan® , Genotyping Console™ , myDesign™ , NetAffx® , OncoScan™ , Powered by Affymetrix™ , PrimeView™ , Procarta® , and QuantiGene® are trademarks or registered trademarks of Affymetrix, Inc. All other trademarks are the property of their respective owners. Products may be covered by one or more of the following patents: U.S. Patent Nos. 5,445,934; 5,744,305; 5,945,334; 6,140,044; 6,399,365; 6,420,169; 6,551,817; 6,733,977; 7,629,164; 7,790,389 and D430,024 and other U.S. or foreign patents. Products are manufactured and sold under license from OGT under 5,700,637 and 6,054,270. Affymetrix, Inc. Tel: +1-888-362-2447  Affymetrix UK Ltd. Tel: +44-(0)-1628-552550  Affymetrix Japan K.K. Tel: +81-(0)3-6430-4020 Panomics Products Tel: +1-877-PANOMICS www.panomics.com  USB Products Tel: +1-800-321-9322 www.usb.affymetrix.com Quick assay turnaround time Axiom Genome-Wide CHB 1 & CHB 2 Array Plate Set is part of Axiom® Genotyping Solution, which uses Axiom® 2.0 Assay. The assay is fully automatable on Affymetrix GeneTitan® Multi- Channel Instrument for array processing. n Minimal operator intervention – load consumables, press start, then view analysis n High throughput – instrument operates overnight and can manage over 760 samples/week n Time efficient – less than 2.5 hours of hands-on time per 96 samples Flexible data analysis software Integrate Microsoft Windows GUI-based Genotyping Console™ Software (GTC) or automation-friendly command line-based Affymetrix Power Tools for completing the primary genotyping analysis. The flexible software workflow with simplified data management allows you to easily share your results and seamlessly integrate with third-party software packages. Sample types supported n gDNA from fresh blood n gDNA from saliva (collected using Oragene® DNA collection kits from DNA Genotek) n Whole-genome amplified (WGA) DNA (amplified from gDNA using QIAGEN Repli-g® kits)